Tsumura & Co. (4540.T)

JPY 4241.0

(1.19%)

Inventory Summary of Tsumura & Co.

  • Tsumura & Co.'s latest annual inventory in 2023 was 117.61 Billion JPY , up 15.62% from previous year.
  • Tsumura & Co.'s latest quarterly inventory in 2024 Q1 was 126.91 Billion JPY , up 7.9% from previous quarter.
  • Tsumura & Co. reported annual inventory of 101.72 Billion JPY in 2022, up 9.68% from previous year.
  • Tsumura & Co. reported annual inventory of 92.75 Billion JPY in 2021, up 14.85% from previous year.
  • Tsumura & Co. reported quarterly inventory of 117.61 Billion JPY for 2023 Q4, up 5.11% from previous quarter.
  • Tsumura & Co. reported quarterly inventory of 117.61 Billion JPY for 2023 FY, up 15.62% from previous quarter.

Annual Inventory Chart of Tsumura & Co. (2023 - 2004)

Historical Annual Inventory of Tsumura & Co. (2023 - 2004)

Year Inventory Inventory Growth
2023 117.61 Billion JPY 15.62%
2022 101.72 Billion JPY 9.68%
2021 92.75 Billion JPY 14.85%
2020 80.75 Billion JPY 10.16%
2019 73.3 Billion JPY 41.51%
2018 51.8 Billion JPY 3.63%
2017 49.99 Billion JPY -4.11%
2016 52.13 Billion JPY -0.4%
2015 52.34 Billion JPY 3.22%
2014 50.71 Billion JPY 16.8%
2013 43.42 Billion JPY 22.1%
2012 35.56 Billion JPY 16.34%
2011 30.56 Billion JPY 38.6%
2010 22.05 Billion JPY -1.24%
2009 22.33 Billion JPY 12.75%
2008 19.8 Billion JPY 0.8%
2007 19.65 Billion JPY 15.1%
2006 17.07 Billion JPY 3.67%
2005 16.46 Billion JPY 5.19%
2004 15.65 Billion JPY 0.0%

Peer Inventory Comparison of Tsumura & Co.

Name Inventory Inventory Difference
Pharma Foods International Co., Ltd. 6.71 Billion JPY -1651.02%
Takeda Pharmaceutical Company Limited 1209.86 Billion JPY 90.279%
Sumitomo Pharma Co., Ltd. 115.35 Billion JPY -1.964%
Shionogi & Co., Ltd. 64.91 Billion JPY -81.182%
Wakamoto Pharmaceutical Co.,Ltd. 2 Billion JPY -5763.108%
Nippon Shinyaku Co., Ltd. 39.11 Billion JPY -200.724%
Kaken Pharmaceutical Co., Ltd. 17.16 Billion JPY -585.128%
Eisai Co., Ltd. 174.65 Billion JPY 32.657%
Morishita Jintan Co., Ltd. 3.18 Billion JPY -3592.81%
Hisamitsu Pharmaceutical Co., Inc. 21.17 Billion JPY -455.421%
Mochida Pharmaceutical Co., Ltd. 30.27 Billion JPY -288.454%
Fuso Pharmaceutical Industries,Ltd. 14.2 Billion JPY -728.165%
Nippon Chemiphar Co., Ltd. 10.72 Billion JPY -996.96%
Kissei Pharmaceutical Co., Ltd. 26.29 Billion JPY -347.277%
Torii Pharmaceutical Co., Ltd. 10.74 Billion JPY -994.917%
Towa Pharmaceutical Co., Ltd. 101.07 Billion JPY -16.369%
Fuji Pharma Co., Ltd. 19.37 Billion JPY -507.176%
Zeria Pharmaceutical Co., Ltd. 14.48 Billion JPY -711.718%
KYORIN Holdings, Inc. 53.47 Billion JPY -119.966%
Taiko Pharmaceutical Co.,Ltd. 1.95 Billion JPY -5925.41%
Daito Pharmaceutical Co.,Ltd. 20.89 Billion JPY -463.025%
SymBio Pharmaceuticals Limited 232.03 Million JPY -50589.997%
MedRx Co., Ltd 10 Million JPY -1176060.0%
Mizuho Medy Co.,Ltd. 1.59 Billion JPY -7266.617%
Solasia Pharma K.K. 122 Million JPY -96306.557%
Modalis Therapeutics Corporation 6.35 Million JPY -1851245.821%
ASKA Pharmaceutical Holdings Co.,Ltd. 20.4 Billion JPY -476.493%
Sawai Group Holdings Co., Ltd. 100 Billion JPY -17.614%
Cyfuse Biomedical K.K. 46.04 Million JPY -255337.072%
Toho Holdings Co., Ltd. 87.28 Billion JPY -34.746%
Koa Shoji Holdings Co.,Ltd. 2.26 Billion JPY -5089.877%